1-n-butyl-3-n-propylxanthine

Also Known As:

1-BPX; XT-44

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Osteoporosis 04/01/1999 - "These results indicate that XT-44 could be a candidate as a therapeutic drug for treating osteopenia including osteoporosis."
2.	Metabolic Bone Diseases (Osteopenia) 04/01/1999 - "These results indicate that XT-44 could be a candidate as a therapeutic drug for treating osteopenia including osteoporosis." 04/01/1999 - "Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models."

1.	Phosphodiesterase 4 Inhibitors
2.	Therapeutic Uses